Nicotine-haloperidol interactions and cognitive performance in schizophrenics

Neuropsychopharmacology

Volumn 15, Issue 5, 1996, Pages 429-436

  Levin, Edward D ^a,b   Wilson, William ^a   Rose, Jed E ^a,b   McEvoy, Joseph ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Haloperidol; Memory; Nicotine; Reaction time; Schizophrenia

Indexed keywords

BENZATROPINE; BENZATROPINE MESILATE; HALOPERIDOL; NICOTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MEMORY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SCHIZOPHRENIA; TREMOR;

EID: 0030297344     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00018-8     Document Type: Article

References (31)

1. Adler LE, Hoffer LD, Wiser A, Freedman R (1993): Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856-1861
2. Andersson K, Fuxe K, Agnati LF (1981a): Effects of a single injection of nicotine on the ascending dopaminergic pathways in rats. Evidence for increased dopamine turnover in the mesostriatal and mesolimbic dopamine neurons. Acta Physiol Scand 112:345-347
3. Andersson K, Fuxe K, Agnati LF, Eneroth P (1981b): Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in male rat brain. Evidence for nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems. Med Biol 59:170-176
4. Benedict RHB, Harris AE, Markow T, McCormick JA, Nuechterlein KH, Asarnow RF (1994): Effects of attention training on information processing in schizophrenia. Schizophr Bull 20:537-546
5. Clarke PBS (1990): Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. Biochem Pharmacol 40:1427-1432
6. Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM (1990): Neuroleptic drug effects on cognitive function in schizophrenia. Schizophr Res 3:211-219
7. Conners CK (1994): The Continuous Performance Test (CPT): Use as a diagnostic tool and measure of treatment outcome. Annual Convention of the American Psychological Association, Los Angeles, CA, Aug 12-16, 1994
8. Conners CK (1995): The Continuous Performance Test. Computer Program, Toronto, Multi-Health Systems
9. Dawe S, Gerada C, Russell MAH, Gray JA (1995): Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology 117:110-115
10. Decina P, Caracci G, Sandik R, Berman W, Mukherjee S, Scapicchio P (1990): Cigarette smoking and neuroleptic-induced Parkinsonism. Biol Psychiatry 28:502-508
11. Fiore MC (1992): Trends in smoking in the United States. The epidemiology of tobacco use. Med Clin North Am 76:289-303
12. Gras-Vincendon A, Danion JM, Grange D, Bilik M, Willard-Schroeder D, Sichel JP, Singer L (1994): Explicit memory, repetition priming and cognitive skill learning in schizophrenia. Schizophr Res 13:117-126
13. Grenhoff J, Aston-Jones G, Svensson TH (1986): Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128:151-158
14. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986): Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143:993-997
15. Jarvik ME, Caskey NH, Wirshing WC (1996): Dopaminergic drugs modulate cigarette smoking. Addiction 91:141
16. Le Moal M, Simon H (1991): Mesocortical dopaminergic network: Functional and regulatory roles. Physiol Rev 71:155-234
17. Levin ED (1992): Nicotinic systems and cognitive function. Psychopharmacology 108:417-431
18. Levin ED, Schantz SL, Bowman RE (1992): Use of the lesion model for examining toxicant effects on cognitive behavior. Neurotoxicol Teratol 14:131-141
19. Levin ED, Conners CK, Sparrow E, Hinton S, Meek W, Rose JE, Ernhardt D, March J (1996): Nicotine effects on attention-deficit/hyperactivity disorder. Psychopharmacology 123:55-63
20. Lichtensteiger W, Hefti F, Felix D, Huwyler T, Melamed E, Schrumpf M (1982): Stimulation of nigrostriatal dopamine neurons by nicotine. Neuropharmacology 21:963-968
21. Lohr JB, Flynn K (1992): Smoking and schizophrenia. Schizophr Res 8:93-102
22. McEvoy J, Freudenreich O, Levin E, Rose J (1995a): Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 119:124-126
23. McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J (1995b): Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 37:550-552
24. Medalia A, Gold J, Merriam A (1988): The effects of neuroleptics on neuropsychological test results of schizophrenics. Arch Clin Neuropsychol 3:249-271
25. Modell J, Tandon R, Beresford T (1989): Dopaminergic activity of the antiparkinsonian agents. J Clin Psychopharmacol 9:347-351
26. O'Farrell TJ, Connors GJ, Upper D (1983): Addictive behaviors among hospitalized schizophrenic patients. Addict Behav 8:329-333
27. Pandurangi AK, Sax KW, Pelonero AL, Goldberg SC (1994): Sustained attention and positive formal thought disorder in schizophrenia. Schizophr Res 13:109-116
28. Reeves D, Bleiberg J, Spector J (1993a): Validation of the ANAM battery in multi-center head injury rehabilitation studies. Arch Clin Neuropsychol 8:356
29. Reeves D, Kane R, Winter K, Raynsford K, Pancella T (1993b): Automated Neuropsychological Assessment Metrics (ANAM): Test Administrator's Guide Version 1.0. St. Louis, Missouri, Institute of Mental Health
30. Verdoux H, Magnin E, Bourgeois M (1995): Neuroleptic effects on neuropsychological test performance in schizophrenia. Schizophr Res 14:133-139
31. Wonnacott S, Irons I, Rapier C, Thorne B, Lunt GG (1989): Presynaptic modulation of transmitter release by nicotinic receptors. In Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds), Progress in Brain Research. New York, Elsevier Science Publishers B.V., pp 157-163